Login to Your Account



Washington Roundup

FDA Begins Blazing Narrow Trail for Approval Shortcut

By Mari Serebrov
Washington Editor

Tuesday, January 15, 2013
Hoping to beef up its arsenal against drug-resistant bacteria, the FDA is taking the first steps to blaze a new approval shortcut for drugs, both small molecules and biologics, that narrowly focus on serious or life-threatening diseases in which there's an unmet need.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription